Company: TVRD
Filing Date: 2025-02-14
Form Type: S-4/A
Source: 0001104659-25-013053
Chunk: 655

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: S-4/A
Chunk 655
---
 Tvardi Chief Medical Officer on January 30, 2023. Narrative to the Summary Compensation Table Tvardi’s board of directors reviews compensation annually for all employees, including its named executive officers. In making compensation determinations, Tvardi considers compensation for comparable positions in the market, individual performance as compared to its expectations and objectives, its desire to motivate its employees to achieve short- and long-term results that are in the best interests of its stockholders and a long-term commitment to its company. Tvardi’s board of directors has historically determined its executive officers’ compensation and has typically reviewed and discussed management’s proposed compensation with its chief executive officer for

376

TABLE OF CONTENTS

all executives other than its chief executive officer. Based on those discussions and its discretion, its board of directors then approved the compensation of each executive officer. Following the completion of this Merger, the compensation committee will determine its executive officers’ compensation in accordance with the terms of its written charter. Annual Base Salary Base salaries for Tvardi executive officers are initially established through arm’s-length negotiations at the time of the executive officer’s hiring, taking into account such executive officer’s qualifications, experience, the scope of such executive officer’s responsibilities and competitive market compensation paid by other companies for similar positions within the industry and geography. Base salaries are reviewed periodically, typically in connection with Tvardi’s annual review process, and adjusted from time to time to realign salaries with market levels after taking into account individual responsibilities, performance, experience and adjustments to reflect cost of living increases. In making decisions regarding salary increases, Tvardi may also draw upon the experience of members of its board of directors with executives at other companies. The 2024 annual base salaries for its named executive officers are set forth in the table below:

| Name                   | ​ | ​ | BaseSalary ($) |   |         |   | ​ |
| Imran Alibhai, Ph.D.   | ​ | ​ | ​              | ​ | 551,050 | ​ | ​ |
| John Kauh, M.D.        | ​ | ​ | ​              | ​ | 412,000 | ​ | ​ |
| Dan Conn, J.D., M.B.A. | ​ | ​ | ​              | ​ | 381,100 | ​ | ​ |

Annual Performance Bonus Opportunity For 2024, Tvardi named executive officers were eligible to receive discretionary annual performance bonuses based on individual performance, company performance or as otherwise determined appropriate, as determined by its